Target intelligence / Profile preview

MSANTD3 pseudogene 1 (MSANTD3P1)

Target
MSANTD3P1
Molecular classification
Processed pseudogene
01

Overview

MSANTD3 pseudogene 1 (MSANTD3P1) is a processed pseudogene derived from the *Myb/SANT-like DNA-binding domain-containing protein 3* (MSANTD3) gene. Pseudogenes are non-coding DNA sequences that resemble protein-coding genes but are generally non-functional due to disabling mutations or a lack of regulatory elements[5][4][7]. MSANTD3P1 is identified in genomic studies based on homology and retrotransposition events but is not known to encode a protein or contribute to recognized biological processes or disease phenotypes. Unlike its parental gene, MSANTD3, which shows oncogenic potential in certain salivary gland cancers, the MSANTD3P1 pseudogene has no established functional, diagnostic, or therapeutic relevance[5][3][4][7]. If you are seeking information on an actionable biological target, consider searching for **MSANTD3** itself rather than its pseudogene form.

Other names
MSANTD3P1Myb/SANT-like DNA-binding domain containing 3 pseudogene 1
02

Mechanism of action

None. MSANTD3P1 is not a functional protein-coding gene, nor targeted by drugs.

03

Biological functions

None established for the pseudogene. Pseudogenes can sometimes regulate parental gene expression via RNA mechanisms (e.g., microRNA decoys), but there is no evidence this occurs with MSANTD3P1.
04

Disease associations

None established for the pseudogene. MSANTD3 gene aberrations have been implicated in a subset of salivary gland cancers, but this has not been shown for the pseudogene.
05

Safety considerations

None. There are no therapeutic challenges or safety issues reported regarding MSANTD3P1.
06

Interacting drugs

None. No drugs are known or predicted to interact with MSANTD3P1.
07

Biomarkers

None. It is not used as a biomarker for patient selection or efficacy monitoring in any clinical or research context.

Beyond the preview

Go deeper on MSANTD3 pseudogene 1 (MSANTD3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSANTD3 pseudogene 1 (MSANTD3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call